"Theon International to Acquire 9.8% Stake in Exosens for €268.7 Million"

"Theon International PLC has signed an agreement to acquire a 9.8% stake in Exosens SA for €268.7 million, making Theon the second largest shareholder in Exosens, a French company specializing in advanced electro-optical technologies. The transaction is subject to regulatory approvals and is expected to close in early Q1 2026. Clifford Chance provided legal advice for the deal."

Clifford Chance advised Theon International PLC (THEON) on its contemplated acquisition of a 9.8% stake in Exosens SA (EXOSENS). The law firm provided legal assistance throughout the transaction, which involves a cash consideration of €268.7 million. Theon has entered into a definitive agreement with HLD Europe SCA, Invest Prince Henri SCA, and Invest Gamma SARL, investment companies belonging to Groupe HLD. Upon completion of the transaction, Theon will become the second largest shareholder in Exosens, a leading French company specializing in advanced electro-optical technologies. The closing of the transaction is subject to regulatory notifications in several countries and is expected to occur in early Q1 2026. The Clifford Chance corporate team involved in this transaction included partners Gilles Lebreton and Aline Cardin, and counsel Katerina Drakoularakou from the Paris office, as well as partner George Hacket and counsel Andrei Manea from the Frankfurt office. Additionally, partner David Tayar, along with associates Hendrik Coppoolse and Marlen Pezzetta, provided advice on the antitrust and foreign direct investment aspects of the deal.

"Theon International to Acquire 9.8% Stake in Exosens for €268.7 Million"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads